List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 3089 studies with search of: Leukemia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Leukemia;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: decitabine;   Drug: vorinostat
2 Completed CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: temsirolimus
3 Recruiting Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
Condition: Leukemia
Interventions: Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis
4 Completed Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: becatecarin
5 Not yet recruiting Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Myeloproliferative Disorders;   Acute Lymphoblastic Leukemia
Interventions: Biological: pretargeted radioimmunotherapy;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Radiation: total-body irradiation;   Other: pharmacological study;   Procedure: peripheral blood stem cell transplantation;   Drug: fludarabine phosphate
6 Completed 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: irofulven
7 Recruiting A Phase 1/2 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Blast-phase Chronic Myelogenous Leukemia;   AML;   ALL;   CML
Intervention: Drug: STA-9090
8 Completed PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: bortezomib
9 Completed Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia;   Myelodysplasia
Intervention: Biological: autologous tumor cells
10 Completed Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia;   Lymphoma
Intervention: Biological: apolizumab
11 Active, not recruiting Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Condition: Leukemia
Intervention: Drug: sorafenib tosylate
12 Completed Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: PR1 leukemia peptide vaccine;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim
13 Completed Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Conditions: Chronic Myeloid Leukemia;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: Dasatinib
14 Completed DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Genetic: Southern blotting;   Genetic: chromosomal translocation analysis;   Genetic: cytogenetic analysis;   Genetic: gene rearrangement analysis;   Genetic: mutation analysis
15 Completed 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cytarabine;   Drug: tanespimycin
16 Active, not recruiting Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condition: Leukemia
Intervention: Drug: alvocidib
17 Recruiting Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Other: biologic sample preservation procedure
18 Active, not recruiting Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Accelerated Phase) Subjects
Condition: Leukemia
Intervention: Drug: Dasatinib
19 Recruiting Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry
20 Active, not recruiting Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
Conditions: Leukemias;   Acute Myeloid Leukemia (AML);   Acute Lymphocytic Leukemia (ALL);   Adult T Cell Leukemia (ATL);   Chronic Myeloid Leukemia (CML-BP);   Chronic Lymphocytic Leukemia (CLL);   Myelodysplastic Syndrome (MDS);   Chronic Myelomonocytic Leukemia (CMML)
Intervention: Drug: Terameprocol (EM-1421)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services